March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
March 9, 2026
The University of Cincinnati Cancer Center’s Bailey Nelson, MD, has been awarded a $50,000 pilot grant from the Cancer Center to open a Phase 1 trial testing if a probiotic supplement can reduce gastrointestinal symptoms for patients undergoing whole pelvis radiotherapy.
March 4, 2026
The University of Cincinnati's Melissa DelBello was featured in a National Geographic article discussing recent research she coauthored that used brain imaging to identify three distinct subtypes of of ADHD, each with its own chemical interactions in the brain.
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
February 23, 2026
The University of Cincinnati's Daniel Arendt was featured in a Jacksonville news station News4Jax report on the increase in fentanyl overdose deaths in seniors.
February 23, 2026
The University of Cincinnati and UC Health have launched the UC/UC Health Addiction Center, a multidisciplinary initiative designed to unite research with clinical and educational expertise to improve addiction prevention and treatment outcomes in the Greater Cincinnati community and beyond.
February 19, 2026
With the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen, the University of Cincinnati Cancer Center’s Blood Cancer Healing Center has brought its full mission to life as a comprehensive blood cancer hub.
February 12, 2026
MSN UK highlighted University of Cincinnati Cancer Center researchers studying the use of a delayed release preparation or wafer of an immunostimulatory molecule known as IL-15 to stimulate the central nervous system immune system after surgery to remove glioblastoma brain tumors.
February 11, 2026
The Cincinnati Business Courier spoke with David Gius, MD, PhD, who was recently named the next director of the University of Cincinnati Cancer Center.
February 11, 2026
The University of Cincinnati’s Fabiano Nery, MD, PhD, has received a five-year, approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to launch a clinical trial testing two new nonpharmacological treatments for teens and young adults with depression.